FBInvestor
Stocks / Prevail Therapeutics Inc- Cvr
Institutional Ownership

Prevail Therapeutics Inc- Cvr

CUSIP 532CVR108RIGQ1 2026

Earnings

Quarterly EPS and revenue are sourced from SEC XBRL financial statements. We ingest the top issuers first; this fills in as coverage expands (or this security isn't mapped to an SEC filer yet).

Coming soon